Skip to main content
OpenTrials

Clinical trial condition

Connective Tissue Diseases

Explore clinical trials studying Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

5,745 public trials 878 recruiting studies
Refine in advanced search Browse all conditions

Connective Tissue Diseases trial results

Completed

A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome

NCT02701985

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +14 more
Locations
  • Wallace Rheumatic Study Center Beverly Hills, California, United States
  • Denver Arthritis Clinic Denver, Colorado, United States
  • Ochsner Clinic Foundation Baton Rouge, Louisiana, United States
  • John Hopkins Bayview Medical Center Baltimore, Maryland, United States
View all 31 locations
View Trial Details
Completed

Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

NCT00993668

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +14 more
Locations
  • Birmingham, Alabama, United States
  • Huntsville, Alabama, United States
  • Tuscaloosa, Alabama, United States
  • Peoria, Arizona, United States
View all 41 locations
View Trial Details
Completed

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

NCT01500278

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • 141 Birmingham, Alabama, United States
  • 214 Tuscaloosa, Alabama, United States
  • 159 Tucson, Arizona, United States
  • 152 Hot Springs, Arkansas, United States
View all 175 locations
View Trial Details
Completed

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

NCT01521923

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • 209 Birmingham, Alabama, United States
  • 170 Huntsville, Alabama, United States
  • 180 Mobile, Alabama, United States
  • 247 Glendale, Arizona, United States
View all 178 locations
View Trial Details
Completed

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

NCT01519791

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • 209 Birmingham, Alabama, United States
  • 170 Huntsville, Alabama, United States
  • 180 Mobile, Alabama, United States
  • 247 Glendale, Arizona, United States
View all 178 locations
View Trial Details
Completed

A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment.

NCT02679001

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Arvika Sjukhus; Reumatologimottagningen - Medicinmottagningen Arvika, Sweden
  • Mälarsjukhuset; Reumatologkliniken Eskilstuna, Sweden
  • Karolinska University Hospital, Huddinge; Rheumatology Huddinge, Sweden
  • Blekingesjukhuset Karlskrona; Medicin, Rheumatology Karlskrona, Sweden
View Trial Details

Related conditions